Evidence map›Paper›PMID 19706676›Full record

ArticleJournal of cell science2009

Ligand-independent signaling by disulfide-crosslinked dimers of the p75 neurotrophin receptor.

Marçal Vilar, Ioannis Charalampopoulos, Rajappa S Kenchappa, Alessandra Reversi, Joanna M Klos-Applequist, Esra Karaca, Anastasia Simi, Carlos Spuch, Soyoung Choi, Wilma J Friedman and 4 more

Open access · bronzeAbstract read
In one paragraph

Article in Journal of cell science, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 37 papers.

0numbers the graph read from it
0cells of the map it votes in
37citing papers in PubMed
1.6field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

37 citing papers in PubMed, 58 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. In vivo functions of p75Trends in pharmacological sciences · 2021
    Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Stoichiometry counts.Proceedings of the National Academy of Sciences of the United States of America · 2019
    Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Review
  17. Review
  18. Structural Basis of p75 Transmembrane Domain Dimerization.The Journal of biological chemistry · 2016
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 5 institutions in 3 countries.

Marçal VilarDivision of Molecular Neurobiology, Department of Neuroscience, Karolinska Institute, 17177 Stockholm, Sweden.
Ioannis Charalampopoulos
Rajappa S Kenchappa
Alessandra Reversi
Joanna M Klos-Applequist
Esra Karaca
Anastasia Simi
Carlos Spuch
Soyoung Choi
Wilma J Friedman
Johan Ericson
Giampietro Schiavo
Bruce D Carter
Carlos F Ibáñez
Karolinska Institutet · SERutgers, The State University of New Jersey · USVanderbilt University · USCancer Research UK · GBThe Honourable Society of Lincoln's Inn · GB

Funding

NEUROTROPHIN SIGNALING THROUGH THE P75 RECEPTORR01NS038220 · NINDS · VANDERBILT UNIVERSITY · PI CARTER, BRUCE D · 1999 to 2014
$4.6M
A Genetic Approach to Study the p75 Neurotrophin ReceptorR01MH071624 · NIMH · RUTGERS THE STATE UNIV OF NJ NEWARK · PI FRIEDMAN, WILMA J · 2006 to 2010
$1.5M
Cancer Research UKNIMH NIH HHS 1 R01 MH071624-01A2NIMH NIH HHS R01 MH071624NINDS NIH HHS R01 NS038220NINDS NIH HHS R01NS038220
6 · The paper itself

Abstract

Dimerization is recognized as a crucial step in the activation of many plasma membrane receptors. However, a growing number of receptors pre-exist as dimers in the absence of ligand, indicating that, although necessary, dimerization is not always sufficient for signaling. The p75 neurotrophin receptor (p75(NTR)) forms disulfide-linked dimers at the cell surface independently of ligand binding through Cys257 in its transmembrane domain. Here, we show that crosslinking of p75(NTR) dimers by cysteine-scanning mutagenesis results in constitutive, ligand-independent activity in several pathways that are normally engaged upon neurotrophin stimulation of native receptors. The activity profiles of different disulfide-crosslinked p75(NTR) mutants were similar but not identical, suggesting that different configurations of p75(NTR) dimers might be endowed with different functions. Interestingly, crosslinked p75(NTR) mutants did not mimic the effects of the myelin inhibitors Nogo or MAG, suggesting the existence of ligand-specific activation mechanisms. Together, these results support a conformational model of p75(NTR) activation by neurotrophins, and reveal a genetic approach to generate gain-of-function receptor variants with distinct functional profiles.

Indexed as

Protein MultimerizationSignal TransductionAmino Acid SequenceAnimalsAxonsCaspase 3Cell DeathChlorocebus aethiopsCOS CellsCross-Linking ReagentsDisulfidesHumansIntracellular Signaling Peptides and ProteinsJNK Mitogen-Activated Protein KinasesLigandsMolecular Sequence DataCaspase 3Cross-Linking ReagentsDisulfidesIntracellular Signaling Peptides and ProteinsJNK Mitogen-Activated Protein KinasesLigandsMutant ProteinsNerve Growth FactorsNF-kappa BReceptor-Interacting Protein Serine-Threonine Kinase 2Receptor, Nerve Growth FactorTNF Receptor-Associated Factor 6

Identifiers

PMID19706676
PMCPMC2736866
OpenAlexW2106458095

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.